ViaLase technology could impact glaucoma care for patients worldwide

Conferences|ASCRS

Kevin Waltz, a consultant for ViaLase, discusses the company's technology: an image-guided femtosecond laser surgical system for the treatment of glaucoma.

Related Videos
Related Content

Glaucoma Foundation’s annual Think Tank Set for June 9-10

June 2nd 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Preservative-free latanoprost vs BAK-preserved latanoprost

May 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

AI used to advance drug delivery system for glaucoma and other chronic diseases

May 25th 2023

Lessons from the Togo Glaucoma Project

May 25th 2023

Glaucoma Foundation’s annual Think Tank Set for June 9-10

June 2nd 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Preservative-free latanoprost vs BAK-preserved latanoprost

May 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

AI used to advance drug delivery system for glaucoma and other chronic diseases

May 25th 2023

Lessons from the Togo Glaucoma Project

May 25th 2023

Glaucoma Foundation’s annual Think Tank Set for June 9-10

June 2nd 2023

Podcast: AI/MR in ophthalmology: The future is now

April 7th 2023

Preservative-free latanoprost vs BAK-preserved latanoprost

May 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

AI used to advance drug delivery system for glaucoma and other chronic diseases

May 25th 2023

Lessons from the Togo Glaucoma Project

May 25th 2023
© 2023 MJH Life Sciences

All rights reserved.